Philadelphia, PA. p.772.
7. Bottenstein, J. and Sato, G. (1978).
Proc. Natl. Acad. Sci. USA 78:514.
8. Bridson, W. and Kohler, P. (1970). J.
Clin. Endocrinol. Metab. 30:538.
9. Colowick, S.
separate digests are
combined in a ratio of 2:3:3.
• Sizes of the 16 pBR328 fragments: 4,907, 2,176, 1,766,
1,230, 1,033, 653, 517, 453, 394, 298 (2 ×), 234 (2 ×),
220, and 154 (2 ×)
T
€514
€1950
Caspase-3
Immunoassay/
Activity Kit
QIA107 Fluorometric Cell
Extracts
DEVD-AFC Yes No 96 Tests Immunocapture of active caspase-3
followed by detection of caspase-3
activity
A., et al. 2004. Blood 105, 2324.
InSolution™ IKK-2 Inhibitor, SC-514
A 25 mM (1 mg/178 ml) solution of IKK-2 Inhibitor,
SC-514 (Cat. No. 401479) in DMSO. A cell-permeable,
potent, reversible, ATP-competitive
Endothelial ( e-NOS) N3893 P y y y
513 Nitric Oxide Synthase, Endothelial ( e-NOS) N2643 P y y n/d
514 Nitric Oxide Synthase, Inducible (i-NOS) N7782 P n/d y y
515 Nitric Oxide Synthase, Inducible (i-NOS
Oxide Synthase, Endothelial ( e-NOS) N2643 18127, 4846 NOS3,Nos3 NP_032739.3,NP_000594.2 P y y n/d
514 Nitric Oxide Synthase, Inducible (i-NOS) N7782 18126, 24599 Nos2 NP_035057.1,NP_036743.3 P n/d y y
Oxide Synthase, Endothelial ( e-NOS) N2643 18127, 4846 NOS3,Nos3 NP_032739.3,NP_000594.2 P y y n/d
514 Nitric Oxide Synthase, Inducible (i-NOS) N7782 18126, 24599 Nos2 NP_035057.1,NP_036743.3 P n/d y y
Cancer Res. 2014
Jun 1;74(11):2962-73.
3. Zecchin A, et al. Endothelial cells and cancer cells: metabolic partners in crime? Curr Opin Hematol. 2015 May;22(3):234-42.
Hypoxia signaling via HIF-1 and